SCHEMBL6981727

SCHEMBL6981727

Cn1cc(-n2c(-c3cn(CCCC#N)c4ccccc34)c(C#N)[nH]c2=O)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 4/20 0.53
CDK9 P50750 4/20 0.53
CCNA2 P20248 2/20 0.51
CDK2 P24941 2/20 0.51
PIM1 P11309 3/20 0.44
CAMK2D Q13557 1/20 0.44
PRKCA P17252 2/20 0.42
PRKACA P17612 1/20 0.42
PRKACG P22612 1/20 0.42
PRKACB P22694 1/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PABPC1 P11940 1/20 0.39
IDH1 O75874 1/20 0.39
CASK O14936 1/20 0.39
RPS6KA5 O75582 1/20 0.39
CCNK O75909 1/20 0.39
STK10 O94804 1/20 0.39
PRKD3 O94806 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977406 0.90 CAMK2D (0.56) CCNT1CDK9PIM1CAMK2DPRKACA
SCHEMBL6983101 0.90 CCNT1 (0.44) CCNT1CDK9CCNA2CDK2PIM1
SCHEMBL6975973 0.89 CAMK2D (0.53) CCNT1CDK9CCNA2CDK2PIM1
SCHEMBL6983267 0.89 CCNE2 (0.45) CCNT1CDK9CDK2PIM1CAMK2D
SCHEMBL6980550 0.89 PRKACA (0.46) CCNT1CDK9CCNA2CDK2PIM1
SCHEMBL6975188 0.89 PRKCA (0.57) CCNT1CDK9CDK2PIM1CAMK2D
SCHEMBL6983953 0.88 CCNT1 (0.43) CCNT1CDK9CCNA2CDK2PIM1
Dimethylamine SCHEMBL6976140 0.87 CCNT1 (0.41) CCNT1CDK9CCNA2CDK2PIM1
SCHEMBL6979590 0.87 CCNT1 (0.42) CCNT1CDK9CCNA2CDK2PIM1
SCHEMBL6973734 0.86 CAMK2D (0.56) CCNT1CDK9CCNA2CDK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346625-B1 ENZYME INHIBITORS FOR PROTEIN KINASES ASTRAZENECA AB (SE) 2002-02-12 US claimed
EP-1095039-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2001-05-02 EP claimed
WO-2000002877-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-01-20 WO claimed
EP-1095039-B1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-27 EP disclosed
US-6346625-B1 ENZYME INHIBITORS FOR PROTEIN KINASES ASTRAZENECA AB (SE) 2002-02-12 US disclosed
EP-1095039-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2001-05-02 EP disclosed
WO-2000002877-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed